Nom & Prénom : | Rejeb Jihene |
Date de naissance : | Mercredi 17 Février 1982 à Mahdia |
Situation familiale : | Mariée avec 2 enfants |
Email : | jihene_rejeb@yahoo.fr |
Adresse : | Boite postale 459, Tabarka, 8010, Tunisie |
Télécharger Curriculum vitae |
Biologie Molléculaire Biochimie |
|
|
Liste des publications
1. Rejeb J, Omezzine A, Rebhi L, Boumaiza I, Mabrouk H, Rhif H, Rejeb NB, Nabli N, Douki W, Abdelaziz AB, Boughzala E, Bouslama A. Association of PON1 and PON2 polymorphisms with PON1 activity and significant coronary stenosis in a Tunisian population. Biochem Genet. 2013 Feb;51(1-2):76-91.
2. Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Kacem S, Rejeb NB, Nabli N, Abdelaziz AB, Boughzala E, Bouslama A. Association of three polymorphisms of scavenger receptor class BI gene (exon8, exon1, intron5) with coronary stenosis in a coronary Tunisian population. Gene. 2012 Dec 15;511(2):383-8.
3. Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Rejeb NB, Nabli N, Abdelaziz AB, Boughzala E, Bouslama A. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population. J Cardiovasc Med. 2012 Sep;13(9):546-53.
4. Rejeb J, Omezzine A, Rebhi L, Boumaiza I, Kaouthar K, Belkahla R, Ben Rejeb N, Nabli N, Ben Abdelaziz A, Boughzala E, Bouslama A. Associations between common polymorphisms of Adenosine Triphosphate-Binding Cassette Transporter A1 and coronary artery disease in a Tunisian population. Arch Cardiovasc Dis. 2010; 103: 530-537.
5. Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Kaouthar K, Kalboussi N, Ben Rejeb N, Nabli N, Abdelaziz AB, Boughzala E, Bouslama A. Elevated Liver Enzymes in Metabolic Syndrome Are Associated With Coronary Stenosis in a Tunisian Population. Metab Syndr Relat Disord. 2010;8(3):249-54.
6. Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Kalboussi N, Laouini A, Ben Rejeb N, Nabli N, Abdelaziz AB, Boughzala E, Bouslama A. Metabolic syndrome is a risk factor for coronary artery disease in a tunisian population. Metab Syndr Relat Disord. 2010;8(2):105-12.
7. Rejeb J, Omezzine A, Rebhi L, Naffeti I, Kchok K, Belkahla R, Bel Hadjmbarek I, Ben Rejeb N, Nabli N, Boujelbene A, Ben Abdelaziz A, Boughzala E, Bouslama A. Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population. Arch Cardiovasc Dis. 2008;101(10):629-36.
8. Moussa A, Rejeb J, Omezzine A, Rebhi L, Boumaiza I, Kacem S, Ben Rejeb N, Boughzala E, Ben Abdelaziz A, Bouslama A. Association between haptoglobin 2-2 genotype and coronary artery disease and its severity in a tunisian population. Biochem Genet. 2014 Jun; 52(5-6):269-82.
9. Fekih O, Triki S, Rejeb J, Neffati F, Douki W, Ommezzine A, Chouchane S, Guediche MN, Bouslama A, Najjar MF. Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes. Endokrynol Pol. 2017;68(1):35-41.
10. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ben Rejeb N, Nabli N, Ben Abdelaziz A, Bouslama A. Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Genet Test Mol Biomarkers. 2012 Dec;16(12):1356-62.
11. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ouedrani A, Ben Rejeb N, Nabli N, Ben Abdelaziz A, Bouslama A. Relationship between leptin G2548A and leptin receptor Q223R gene polymorphisms and obesity and metabolic syndrome risk in Tunisian volunteers. Genet Test Mol Biomarkers. 2012 Jul;16(7):726-33.
12. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Rejeb NB, Nabli N, Abdelaziz AB, Bouslama A. Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Metab Syndr Relat Disord. 2011 Dec;9(6):419-26.
13. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ben Rejeb N, Nabli N, Ben Abdelaziz A, Boughzala E, Bouslama A. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary artery disease in Tunisian coronaries. J Cardiovasc Med (Hagerstown). 2011 Sep;12(9):619-24.
14. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Kalboussi N, Ben Rejeb N, Nabli N, Abdelaziz AB, Boughazala E, Bouslama A. Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol Are Better Risk Markers for Coronary Artery Disease than Low-Density Lipoprotein Cholesterol in Hypertriglyceridemic Metabolic Syndrome Patients. Metab Syndr Relat Disord. 2010;8(6):1-8.
15. Hamdouni H, Achour O, Naija S, Rejeb J, Aounallah M, Mhiri M, Noureddine M, Ben Rejeb N, Omezzine A, Ben Amor S, Benammou S & Bouslama A. Association between dementia and vascular disease-associated polymorphisms in a Tunisian population. International Journal of Neuroscience, 2017
16. Boumaiza I, Omezzine A, Romdhane M, Rejeb J, Rebhi L, Bouacida L, Neffati S, Ben Rejeb N, Ben Abdelaziz A, Bouslama A. Metabolic Syndrome according to Three Definitions in Hammam-Sousse Sahloul Heart Study: A City Based Tunisian Study. Advances in Epidemiology. Volume 2014, Article ID 891297, 10 pages
17. Lamia R, Asma O, Slim K, Jihéne R, Imen B, Ibtihel BH, Kaouther K, Radhia B, Nabila BR, Naoufel N, Ahmed BA, Essia B, Ali B. Association of four apolipoprotein B polymorphisms with lipid profile and stenosis in Tunisian coronary patients. J Genet. 2012 Apr; 91(1):75-9.
18. Rebhi L., Omezzine A., Belhadjmbarek I., Rejeb J., Bouchhima M.A., Amri W., Benrejeb N., Nabli N., Abdelaziz A., Zemni J., Boughzala E., Bouslama A. B-type natriuretic peptide is a prognostic marker after myocardial infarction: Two-years survival study of 86 patients. Immuno-analyse et biologie spécialisée 2010;25 :266-271.
19. Fekih O, Triki S, Hellara I, Neffati F, Rejeb J, Ommezzine A, Chouchane S, Guediche MN, Bouslama A, Najjar MF. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities? J Clin Lipidol. 2014 May-Jun;8(3):249-55.
20. Rebhi L, Kchok K, Omezzine A, Kacem S, Rejeb J, Ben HadjMbarek I, Belkahla R, Boumaiza I, Moussa A, Ben Rejeb N, Nabli N, Boughzala E, Ben Abdelaziz A, Bouslama A. Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population. Mol Biol Rep. 2012 Nov; 39(11):9893-901.
21. Ezzaher A, Mouhamed DH, Mechri A, Neffati F, Rejeb J, Omezzine A, Douki W, Bouslama A, Gaha L, Najjar MF. Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene. J Affect Disord. 2012 Jun;139(1):12-7.
22. I. Boumaiza, S. Berriri, A. Omezzine, L. Rebhi, J. Rejeb, N. Ben Rejeb, N. Nabli, A. Ben Abdellaziz, A. Bouslama. Effects of dietetic WHO's recommendations on HDL-C level in a Tunisian obese group. Immuno-analyse & Biologie Spécialisée, Volume 27, Issue 3, June 2012, Pages 97-103.
23. Zayani N, Omezzine A, Boumaiza I, Achour O, Rebhi L, Rejeb J, Ben Rejeb N, Ben Abdelaziz A, Bouslama A. Association of ADIPOQ, leptin, LEPR, and resistin polymorphisms with obesity parameters in Hammam Sousse Sahloul Heart Study (“HSHS”). J Clin Lab Anal. 2017;31:e22148.
24. Achour O, Elmtaoua S, Zellama D, Omezzine A, Moussa A, Rejeb J, Boumaiza I, Bouacida L, Ben Rejeb N, Achour A, Bouslama A. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis. J Nephrol. 2015 Nov 11.
25. Rebhi L, Omezzine A, Kchok K, Belkahla R, Ben Hadjmbarek I, Rejeb J, Ben Rejeb N, Nabli N, Bibi A, Massoud T, Abdelaziz A, Boughzala E, Bouslama A. 5' ins/del and 3' VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease. Clin Chem Lab Med. 2008; 46(3):329-34.
26. R. Belkahla, A. Omezzine, K. Kchok, L. Rebhi, I. Ben Hadj Mbarek, J. Rejeb, N. Ben Rejeb, N. Slimane, N. Nabli, A. Ben Abdelaziz, E. Boughzala, A. Bouslama. Effet des polymorphismes des enzymes clés du métabolisme de l’homocystéine sur l’homocystéinémie et le risque coronarien chez une population tunisienne. Annales de Cardiologie et d’Angéiologie. 2008 ; 57 219–224.
Participation au Projet de recherche (HSHS)
Participation aux manifestations et activités scientifiques
Communications scientifiques affichées (Congrès International et Nationales)
Communications scientifiques orales
Séminaire, workshop et ateliers de formation
Salon de publication
|
|
J’ai acquis une expérience d’enseignement pendant 5 années universitaires en tant qu’assistante universitaire à l’Institut Supérieur de Biotechnologie de Béja dans laquelle j’ai eu l’opportunité d’assurer des séances de cours, des séances de travaux pratiques et de travaux dirigées pour diverses matières comme la biochimie structurale, la biologie moléculaire, la biochimie métabolique, l’enzymologie et autres. J’ai aussi participation à un jury de soutenance en tant qu'examinateur de projets de fin d'étude.
|
|